Literature DB >> 28879

Renin-suppressive potency of various beta-adrenergic blocking agents at supine rest and during upright exercise.

F R Bühler, G Marbet, U Patel, F Burkart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 28879     DOI： 10.1042/cs048061s

Source DB:  PubMed          Journal:  Clin Sci Mol Med Suppl        ISSN： 0144-4107


× No keyword cloud information.
  8 in total

Review 1.  Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents.

Authors:  G Cocco; F Burkart; D Chu; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

2.  Long term effect of timolol and hydrochlorothiazide, or hydrochlorothiazide and amiloride, in essential hypertension.

Authors:  H Castenfors
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

3.  Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions.

Authors:  B G Hansson; J F Dymling; H Hedeland; U L Hulthén
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

4.  Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.

Authors:  B G Hansson; J F Dymling; P Manhem; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

5.  Acute changes in renal function induced by bisoprolol, a new cardioselective beta-blocking agent.

Authors:  Z Glück; F C Reubi
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Time-course of the anti-hypertensive action of atenolol: comparison of response to first dose and to maintained oral administration.

Authors:  G Leonetti; L Terzoli; C Bianchini; C Sala; A Zanchetti
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

Review 7.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

8.  Studies on the pharmacokinetics and pharmacodynamics of atenolol in man.

Authors:  J D Fitzgerald; R Ruffin; K G Smedstad; R Roberts; J McAinsh
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.